Can research consents be signed electronically?

Yes. Electronic signatures are generally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state laws (UETA or equivalent). Verify IRB acceptance and any jurisdictional exceptions before eSigning.

Is a HIPAA authorization required alongside consent?

If protected health information will be used or disclosed beyond routine study operations, a HIPAA authorization is typically required. Include HIPAA language or a combined consent/authorization as approved by the IRB.

What authentication level is sufficient?

Authentication should match risk. Email link or SMS code is common for low‑risk consents; use KBA or two‑factor methods for higher‑risk or regulated data to strengthen attribution.

Do I need notarization for research consents?

Most research consents do not require notarization. If a state or sponsor requires notarization or a witnessed signature, follow that rule. RON may be acceptable where the state permits it.

How long must signed consents be kept?

Retention depends on sponsor, IRB, and regulatory rules. Follow HIPAA (6 years), sponsor requirements, and applicable federal rules; many sites retain consents for at least 3 years post‑study.

Can a participant withdraw consent electronically?

Yes. Provide a documented withdrawal process that is auditable and preserves prior records. Withdrawal does not retroactively invalidate processing already lawfully completed under prior consent.

Electronic Signature
Templates
Healthcare
Healthcare Research Conditions

Healthcare Research Conditions

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Research Conditions

This Healthcare Research Conditions form documents the terms under which the Patient agrees to participate in the clinical research study identified below. Participation is voluntary. The Patient should read all sections carefully and initial or check the consent items that apply.

Patient Information

Full Legal Name

Date of Birth:

Gender:

Medical Record No.:

Address

Phone:

Email:

Emergency Contact

Name

Relationship:

Phone:

Insurance Information

Insurance Provider

Policy Number:

Group No.:

Subscriber Name

Medical History

Current Medications Allergies (medications, foods, latex, etc.) Prior Surgeries / Hospitalizations Chronic Conditions / Diagnoses

Study Identification and Procedures

Study Title:

Principal Investigator:

Study ID / Protocol Number:

Brief Description of Procedures (what will happen)

Conditions of Participation and Authorizations

By initialing or checking the boxes below, the Patient acknowledges and authorizes the corresponding conditions. Authorization of one item does not obligate authorization of others unless specified.

I consent to participate in the research procedures described above.

I authorize the research team to access my relevant medical records and test results for purposes of the study.

I authorize collection and storage of biological samples (blood, tissue, other) as described in the protocol.

I authorize genetic or genomic analysis of my samples, including sequencing and interpretation.

I authorize use of my de-identified data and samples for future research related to this topic.

I authorize audio and/or video recording during study procedures as necessary for research documentation.

I authorize sharing of de-identified data and materials with collaborators, including commercial partners, for research and development.

Risks, Benefits, and Alternatives

The research team has explained the reasonably foreseeable risks, discomforts, and possible side effects of participation in this study. These may include physical risks, psychological distress, loss of confidentiality, allergic reactions, or other risks specific to procedures described. The Patient acknowledges that not all risks are known and that unexpected risks may occur.

I acknowledge that the risks and potential discomforts have been explained to me.

Potential benefits may include improved clinical management, contribution to scientific knowledge, or no direct benefit. Alternatives to participation, including standard clinical care and other available treatments, have been discussed.

I understand the potential benefits and alternatives to participation.

Compensation, Costs, and Treatment of Injuries

Compensation / Reimbursement Participant Costs / Insurance Treatment of Research-Related Injuries

Confidentiality and Use of Health Information

The research team will maintain confidentiality to the extent permitted by law. Identifiable health information that is collected or used for this study will be protected and may be disclosed to authorized study personnel, oversight committees, and regulatory authorities as required. De-identified data may be retained and used for future research. The Patient's decision whether to authorize use of protected health information (PHI) is voluntary and will not affect access to other health care services.

I authorize use and disclosure of my protected health information for purposes of this research study as described above.

I authorize the use of de-identified or anonymized data and samples for future ethically approved research.

Data Retention Period

Withdrawal, Revocation, and Questions

The Patient may withdraw from the study at any time without penalty or loss of benefits to which the Patient is otherwise entitled. Withdrawal may not remove data already collected and used in analyses; the research team may retain data and samples already gathered as described above. Withdrawal procedures, including how to contact the study team, are provided below.

I understand my right to withdraw and that withdrawal instructions were provided.

Study Contact for Questions or Withdrawal

Authorization and Expiration

By signing below, the Patient authorizes the use and disclosure of health information as described and agrees to the conditions of participation checked above. This authorization will remain in effect until the expiration date entered below or until revoked in writing by the Patient, except to the extent that the research team has already acted in reliance on this authorization.

Authorization Expiration Date

Participant Representations and Certification

I certify that I have read this form or that it was read to me, that the study and the conditions of participation were explained to my satisfaction, and that I have had the opportunity to ask questions. I understand that participation is voluntary and that I may withdraw at any time. I authorize the use of my health information and samples consistent with selections I have indicated above.

Patient Name:

Signature:

Date:

If signed by guardian, print name:

Relationship to Patient:

What Healthcare Research Conditions Cover

Healthcare Research Conditions are written terms that define how clinical or health-related research is conducted, including participant eligibility, consent requirements, data handling, privacy protections, and procedural safeguards. These documents typically combine informed consent elements, data-use limitations, oversight and reporting obligations, and any conditions for participant compensation or withdrawal. They are used to document participant agreement, meet Institutional Review Board (IRB) requirements, and demonstrate compliance with federal laws such as HIPAA and applicable state electronic-signature statutes.

Why clear conditions matter for research integrity

Well‑drafted Healthcare Research Conditions protect participants, clarify investigator responsibilities, and provide an auditable record for IRBs, sponsors, and regulators. They support informed consent, reduce legal risk, and help ensure data handling meets HIPAA and other applicable rules.

Who typically prepares and signs these conditions

Accurate preparation and proper signatures provide a defensible record for audits, sponsor reviews, and potential regulatory inquiries.

Principal investigators and study coordinators responsible for protocol compliance and participant enrollment.
Institutional Review Boards and compliance officers who review and approve consent language and safeguards.
Study participants or legally authorized representatives who provide informed consent and sign authorization forms.

Typical signers and approvers

Research Coordinator

Coordinates participant enrollment, confirms eligibility, explains conditions to participants, and ensures the consent process follows IRB-approved procedures. Usually collects signatures and uploads completed records to the study file.

Principal Investigator

Holds ultimate responsibility for study conduct and compliance, reviews consent materials, authorizes study changes, and signs delegation or sponsor agreements when required.

Core sections of a professional Healthcare Research Conditions document

A complete set of conditions organizes consent and operational obligations so investigators, participants, and monitors can find critical details quickly.

Scope of Research

Concise description of study purpose, procedures, visit schedule, and which interventions or data collections are covered under the agreement.

Participant Rights

Plain-language explanation of voluntary participation, right to withdraw, confidentiality protections, and how participants can ask questions or raise concerns.

Data Use & Sharing

Specifies what data will be collected, retention, de‑identification steps, permitted secondary uses, and any data sharing with sponsors or repositories.

HIPAA Authorization

If PHI is involved, a HIPAA authorization or combined consent must detail the categories of PHI, who may use/disclose it, and expiration/redistribution terms.

Compensation & Costs

Describes participant compensation, reimbursement, or costs to the participant, plus conditions under which payments may be withheld.

Termination & Reporting

Explains conditions for study discontinuation, adverse event reporting, and obligations for notifying participants and the IRB.

Essential information to capture

Full name: Participant legal name

Date of birth: MM/DD/YYYY format

Study ID: Local protocol or identifier

HIPAA consent: Signed authorization status

Contact details: Phone and email for follow-up

Signature block: Signed name and date

Step-by-step: completing Healthcare Research Conditions

Follow a consistent sequence to reduce errors and ensure regulatory and IRB compliance for each signed record.

01

Prepare documents: Use the IRB‑approved version and include HIPAA language if PHI is used.
02

Verify identity: Confirm participant identity with ID or institutional process before signing.
03

Capture consent: Have participant review, initial required sections, then sign and date.
04

Store record: Save signed record in the secure study repository with audit trail.

Recommended online workflow settings

Configure the digital workflow to match IRB requirements, ensure signer authentication, and preserve an auditable history.

Field	Configuration
Authentication	Email or SMS code; use stronger KBA for higher risk
Signature Order	Define signer sequence to match consent process
Attachments	Allow upload of ID or supporting documents
Audit Trail	Enable full event logging and timestamping

Technical requirements for eSubmission and storage

Use platforms that offer audit trails, role-based access, and the option for a Business Associate Agreement when required by HIPAA.

Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace
File formats: PDF, DOCX, HTML, Excel supported
Security: TLS 1.2/1.3 in transit; AES-256 at rest

Typical routing and submission flow

A clear routing process ensures signatures are captured in the right order and copies stored with provenance.

Upload document: Sender uploads IRB‑approved PDF or template
Place fields: Add signature, initials, and date fields
Send to signer: Deliver via secure link or email invite
Capture signed copy: Signed PDF and audit trail saved to repository

Common mistakes to avoid

Using a non‑IRB approved consent version that was not reviewed or stamped by the IRB, risking noncompliance with approval conditions.
Failing to obtain HIPAA authorization when the protocol requires PHI use, which can block data access and incur compliance issues.
Accepting signatures without verifying signer identity or representative authority, creating ambiguity during audits or adverse event reviews.
Storing signed records in unsecured locations or overwriting originals, resulting in loss of provenance and auditability.

Key legal and regulatory risks

HIPAA violation: Civil and criminal penalties; enforcement by HHS OCR

IRB noncompliance: Suspension of study or funding restrictions

Data breach: Notification obligations and potential fines

Invalid consent: May render collected data unusable for analysis

Contract breach: Sponsor remedies or termination rights

Recordkeeping failure: Regulatory citations and corrective actions

Practical tips for accurate completion

Adopt consistent controls and document handling procedures to reduce rework, preserve evidence, and simplify audits.

Use IRB‑approved text

Always use the version of consent language approved by the IRB. Maintain version control and document amendment approvals to demonstrate compliance during monitoring visits.

Verify signer identity

Confirm participant identity with institutional ID or approved credentials. For vulnerable populations, confirm legally authorized representative status before accepting consent.

Record audit details

Capture time stamps, IP address, authentication method, and signer email for each executed document. Preserve the audit trail alongside the signed file for inspections.

Limit PHI exposure

Collect only necessary PHI, de‑identify data when feasible, and document the legal basis for any data sharing to satisfy HIPAA and IRB requirements.

How organizations use signed research conditions

Real-world examples show how electronic workflows reduce friction while maintaining compliance with oversight requirements.

Fertility Centers of Illinois

A fertility clinic digitized patient consent to collect signatures remotely and track authorizations efficiently.

Used auditable eSign workflows for clinical forms.
"The airSlate SignNow team has been exceptional, responsive, the API has been great, and we're extremely happy that we chose airSlate SignNow as a company."

BIS

An enterprise adopter standardized consent and contract signing across offices to centralize recordkeeping.

Implemented SOC 2 controls and structured audit logs.
"We felt most comfortable with airSlate SignNow given their SOC 2 certification and strict focus on ESIGN and UETA act compliance."

How to download, save, and export executed records

Preserve signed records in formats that retain audit metadata and are widely accepted for review or archival use.

PDF archive

Export a signed PDF/A file that includes the audit trail and timestamps for long‑term preservation and legal review.

Native formats

Save source DOCX or template copies for amendment tracking; avoid overwriting original signed files.

Download copies

Provide each signer and the study file with an identical signed copy plus certificate of completion.

Secure storage

Store in encrypted repositories with role-based access and regular backups to preserve integrity.

eSignature vendor comparison for Healthcare Research Conditions

Compare basic pricing and compliance features across common eSignature vendors. signNow is shown first per comparative format requirements.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about Healthcare Research Conditions

Answers to common practical and compliance questions about preparing, signing, and storing research conditions.

Need help? Contact support

Can research consents be signed electronically?
Yes. Electronic signatures are generally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state laws (UETA or equivalent). Verify IRB acceptance and any jurisdictional exceptions before eSigning.
Is a HIPAA authorization required alongside consent?
If protected health information will be used or disclosed beyond routine study operations, a HIPAA authorization is typically required. Include HIPAA language or a combined consent/authorization as approved by the IRB.
What authentication level is sufficient?
Authentication should match risk. Email link or SMS code is common for low‑risk consents; use KBA or two‑factor methods for higher‑risk or regulated data to strengthen attribution.
Do I need notarization for research consents?
Most research consents do not require notarization. If a state or sponsor requires notarization or a witnessed signature, follow that rule. RON may be acceptable where the state permits it.
How long must signed consents be kept?
Retention depends on sponsor, IRB, and regulatory rules. Follow HIPAA (6 years), sponsor requirements, and applicable federal rules; many sites retain consents for at least 3 years post‑study.
Can a participant withdraw consent electronically?
Yes. Provide a documented withdrawal process that is auditable and preserves prior records. Withdrawal does not retroactively invalidate processing already lawfully completed under prior consent.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now